 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Laboratory Infrastructure Solutions |
| Street 1: | 511-5 Freeman Str |
| Street 2: | Midstream estate |
| City: | Midrand |
| Province: | Gauteng |
| Post Code: | 1683 |
| Country: | South Africa |
| Phone: | +27 82 733 5276 |
| Email: | info@startalab.co.za |
| Web Site: | http://www.startalab.co.za |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| Laboratory Infrastructure Solutions (LIS) specialises in the manufacturing and deployment of specilised medical infrastructure. LIS brought to the market the containerized molecular laboratory, a bio safety level three (BSL3)laboratory ideally suited to TB prevalence surveys. LIS plans to make its infrastructure, typically housed and transported in a shipping container to deployment sites all over the world. |
|
| Total number of staff in your organization: | 1 - 5 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| What is your organization's annual budget (USD) dedicated to TB? | Unable to disclose amount |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Our containerized infrastructure makes logistical and business sense and contributes to predictable service and optimal research quality. These are the perspectives that LIS has opened up to you: • LIS combines the implementation of quality laboratory systems with quality laboratory environments. • LIS's rapid medical infrastructure is ideally suited to environments where normal construction processes and quality are unpredictable and costly. As with infrastructure risks, operational quality systems are often one of the biggest, but often most elusive, contributors to service failure. Our infrastructure solutions offers clean, ready made environments that deploys on minimal site preparation of services: plinth, water, electricity and drainage – we help you to plan the process. |
|
Geographical Reach | |
| Which country is your headquarters located in: | South Africa |
| Which WHO region is the main focus of your work: | Global |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Botswana Haiti Peru South Africa Zambia |
Specializations | |
|
Delivery of health services and care Technical Assistance |
Specializations in Countries | |
| Delivery of health services and care | Haiti |
| Delivery of health services and care | Peru |
| Delivery of health services and care | South Africa |
| Delivery of health services and care | Zambia |
| Technical Assistance | Botswana |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Laboratory Strengthening: Laboratory Infrastructure Solutions - manufactures containerized BSL3 laboratory, a safe, rapid deployment solution for areas which require reliable healthcare infrastructure. New Diagnostics: Our laboratory and other medical infrastructure solutions makes it possible to take new diagnostic technology to communities that need it most. |
|
Declaration | |
| Declaration of interests: no conflict of interest | |
| Application date: | November 3, 2011 |
| Last updated: | February 23, 2013 |